The Role of Toll-Like Receptors in Osteoclastogenesis

por Yim, Mijung
Publicado 2020

Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways

por Zheng, Ting, Kim, Na-Young, Yim, Mijung
Publicado 2017

FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection

por Kang, Ju-Hee, Kim, Minji, Yim, Mijung
Publicado 2021

Iris Koreana NAKAI Inhibits Osteoclast Formation via p38-Mediated Nuclear Factor of Activated T Cells 1 Signaling Pathway

por Lee, Hwa-Yeong, Jung, Ji-Eun, Yim, Mijung
Publicado 2023

Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract of Euphorbia Lathyris L

por Kang, Ju-Hee, Lim, Hyojung, Jeong, Ji-Eun, Yim, Mijung
Publicado 2016

Rolipram, a Phosphodiesterase 4 Inhibitor, Stimulates Inducible cAMP Early Repressor Expression in Osteoblasts

por Cho, Eun Sook, Yu, Ja Heon, Kim, Mi Sun, Yim, Mijung
Publicado 2005

The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss

por Zheng, Ting, Kang, Ju-Hee, Sim, Jung-Sun, Kim, Jung-Woo, Koh, Jeong-Tae, Shin, Chan Soo, Lim, Hyungsik, Yim, Mijung
Publicado 2017